journal article·2021-09-13

Regulation of an Antimicrobial Peptide GL13K-Modified Titanium Surface on Osteogenesis, Osteoclastogenesis, and Angiogenesis Base on Osteoimmunology

Lin Zhou, Yu Han, Jiamin Ding, Xuxi Chen, Shiying Huang, Xiaojie Xing, Dong Wu, Jiang Chen

Publisher page

Abstract

Creating a pro-regenerative immune microenvironment around implant biomaterial surfaces is significant to osseointegration. Immune cells, especially macrophages that participate in the osseointegration, including osteogenesis, osteoclastogenesis, and angiogenesis, should be considered when testing biomaterials. In this study, we immobilized an antimicrobial peptide GL13K with immunomodulatory properties onto a titanium surface via silanization. The modified surfaces show good biocompatibility with bone mesenchymal stromal cells (BMSCs), human umbilical vein endothelial cells (HUVECs), and RAW264.7. By co-culturing BMSCs with RAW264.7, we found that the GL13K-coated titanium surfaces could promote late-stage osteogenesis as demonstrated by the upregulated expression of recombinant collagen type I alpha 1 (COL-1α1) and more extracellular matrix mineralization, while the early phase remained unchanged. The surfaces inhibited the osteoclastogenic differentiation of RAW264.7 cells by restraining nuclear factor-activated T cells, cytoplasmic 1 (NFATc1), the main factor of the receptor activator of nuclear factor-κ B, and the receptor activator of the nuclear factor-κ B ligand signaling pathway, from entering the nucleus and further reduced the expression of the activating osteoclastogenic tartrate-resistant acid phosphatase gene. Moreover, the GL13K-coated titanium surface demonstrated significant promotion of angiogenesis differentiation of HUVECs as indicated by the upregulated expression of essential angiogenesis function genes, including hypoxia-inducible factor-1α, endothelial nitric oxide synthase, kinase insert domain receptor, and vascular endothelial growth factor A (HIF-1α, eNOS, KDR, and VEGF-A). Taken together, these results demonstrated that the GL13K coating had properties of osteogenesis, angiogenesis, and anti-osteoclastogenesis via its immunomodulatory potential.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Metabolism and Diseases · S100 Proteins and Annexins · Inflammatory mediators and NSAID effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School and Hospital of Stomatology, Fujian Medical University, Fuzhou 350001, People’s Republic of China

Stomatological Key Lab of Fujian College and University, Fujian Medical University, Fuzhou 350001, People’s Republic of China

Department of Oral Mucosa Affiliated Stomatological Hospital of Fujian Medical University, Fuzhou 350001, People’s Republic of China

Institute of Stomatology, Fujian Medical University, Fuzhou 350001, People’s Republic of China

Fujian Provincial Engineering Research Center of Oral Biomaterial, Fuzhou 350001, People’s Republic of China

Research Center of Dental Esthetics and Biomechanics, Fujian Medical University, Fuzhou 350001, People’s Republic of China

Research Center of Dental and Craniofacial Implants, Fujian Medical University, Fuzhou 350001, People’s Republic of China

Funding

Fujian Provincial Health Commission · Natural Science Foundation of Fujian Province · National Natural Science Foundation of China

References (45)

Show source-provided references
1. 10.3389/fimmu.2019.0259510.3389/fimmu.2019.02595 ↗
2. 10.2183/pjab.83.13610.2183/pjab.83.136 ↗
3. 10.1055/s-0033-134948610.1055/s-0033-1349486 ↗
4. 10.1007/s00223-018-0417-110.1007/s00223-018-0417-1 ↗
5. 10.1038/nri206210.1038/nri2062 ↗
6. 10.1016/j.biomaterials.2011.05.07810.1016/j.biomaterials.2011.05.078 ↗
7. 10.1016/j.biomaterials.2015.12.01710.1016/j.biomaterials.2015.12.017 ↗
8. 10.2174/1574888x1466619021416381510.2174/1574888x14666190214163815 ↗
9. 10.1074/jbc.M60799920010.1074/jbc.M607999200 ↗
10. 10.1002/stem.104010.1002/stem.1040 ↗
11. 10.1039/c6bm00290k10.1039/c6bm00290k ↗
12. 10.1016/j.biomaterials.2014.02.01210.1016/j.biomaterials.2014.02.012 ↗
13. 10.1111/cid.1257810.1111/cid.12578 ↗
14. 10.2144/00011375410.2144/000113754 ↗
15. 10.3390/ma809526910.3390/ma8095269 ↗
16. 10.1002/jbm.a.1027510.1002/jbm.a.10275 ↗
17. 10.1155/2018/136295810.1155/2018/1362958 ↗
18. 10.1002/jbm.a.3007510.1002/jbm.a.30075 ↗
19. 10.1111/j.1600-0501.2011.02325.x10.1111/j.1600-0501.2011.02325.x ↗
20. 10.1016/j.biomaterials.2012.09.03210.1016/j.biomaterials.2012.09.032 ↗
21. 10.1016/j.colsurfb.2015.03.00810.1016/j.colsurfb.2015.03.008 ↗
22. 10.1016/j.colsurfb.2017.10.00710.1016/j.colsurfb.2017.10.007 ↗
23. 10.1016/j.matdes.2018.07.00510.1016/j.matdes.2018.07.005 ↗
24. 10.1189/jlb.5VMR0415-166R10.1189/jlb.5VMR0415-166R ↗
25. 10.1021/am507649n10.1021/am507649n ↗
26. 10.1016/j.ajpath.2010.08.00310.1016/j.ajpath.2010.08.003 ↗
27. 10.1016/j.cell.2007.07.02510.1016/j.cell.2007.07.025 ↗
28. 10.1002/adma.20150135110.1002/adma.201501351 ↗
29. 10.3390/ijms16081814910.3390/ijms160818149 ↗
30. 10.1016/s0142-9612(03)00580-510.1016/s0142-9612(03)00580-5 ↗
31. Mavrogenis A. F. · J. Musculoskeletal Neuronal Interact. · 2009 · 9 · 61
32. 10.1007/s00418-018-1636-210.1007/s00418-018-1636-2 ↗
33. 10.1007/s00281-019-00754-310.1007/s00281-019-00754-3 ↗
34. 10.1016/s1534-5807(02)00369-610.1016/s1534-5807(02)00369-6 ↗
35. 10.1111/j.1600-065X.2009.00821.x10.1111/j.1600-065X.2009.00821.x ↗
36. 10.1084/jem.2005115010.1084/jem.20051150 ↗
37. 10.1021/am500885v10.1021/am500885v ↗
38. 10.1038/nature1314510.1038/nature13145 ↗
39. 10.1016/j.peptides.2018.04.01710.1016/j.peptides.2018.04.017 ↗
40. 10.1016/j.actbio.2011.09.00810.1016/j.actbio.2011.09.008 ↗
41. 10.1016/j.actbio.2019.06.05810.1016/j.actbio.2019.06.058 ↗
42. 10.1016/j.biomaterials.2019.11926910.1016/j.biomaterials.2019.119269 ↗
43. 10.1111/cid.1227410.1111/cid.12274 ↗
44. 10.1016/j.biomaterials.2017.05.02010.1016/j.biomaterials.2017.05.020 ↗
45. 10.1016/j.biomaterials.2015.08.02710.1016/j.biomaterials.2015.08.027 ↗